Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 8
Submit an article Journal homepage
89
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Anemia in Multiple Myeloma: Role of Deregulated Plasma Cell Apoptosis

Marco Tucci DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Piazza G. Cesare, 11-70124 Bari, Italy
,
Daniela Grinello DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Piazza G. Cesare, 11-70124 Bari, Italy
,
Paola Cafforio DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Piazza G. Cesare, 11-70124 Bari, Italy
,
Franco Silvestris DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Piazza G. Cesare, 11-70124 Bari, Italy
&
Franco Dammacco DIMO, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Piazza G. Cesare, 11-70124 Bari, Italy
Pages 1527-1533 | Published online: 01 Jul 2009

  • Doll. D.C. and Weiss. R.B. (1985) "Neoplasia and the erythron". Journal of Clinical Oncology 3, 429-446.
  • Kyle. R.A. (1975) "Multiple myeloma: review of 869 cases". Mayo Clinical Proceedings 50, 29-40.
  • MacLennan, I.C., Drayson, M. and Dunn. J. (1994) "Multiple myeloma". British Medical Journal 308, 1033-1036.
  • Means. R.T. and Krantz. S.B. (1992) "Progress in understanding the pathogenesis of the anemia of chronic disease". Blood 80. 1639-1647.
  • Merko. F., Bergui, L. Gregoretti. M.G., Ghia. P., Aimo. G., Lindley, I.J. and Caligaris-Cappio, F. (1993) "Cytokines involved in the progression of multiple myeloma", Clinical and Experimental Immunology 92, 27-31.
  • Ludwig. H., Fritz, E., Kotzmann. H., Höcker. P., Gisslinger. H. and Barnas. U. (1990) "Erythropoietin treatment of anemia associated with multiple myeloma". New England Journal of Medicine 322. 1693-1699.
  • Carton. J.P., Gertz, M.A., Witzig, T.E., Greipp, P.R., Lust. J.A., Schroder, G. and Kyle, R.A. (1995) "Epoetin alfa for the treatment of the anemia of multiple myeloma", Archives of Internal Medicine 155, 2069-2074.
  • Silvestris, P., Romito. A., Fanelli, P., Vacca, A. and Dammacco, F. (1995) "Long-term therapy with recombinant human erythropoietin (rHuEPO) in progressing multiple myeloma: in vivo erythropoietic and immunomodulatory effects", Annals of Hematologv 70, 313-318.
  • Dammacco. F., Castoldi, G. and Rodjer, S. (2001) "Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma". British Journal of Haematology 113, 172-179.
  • Barlogie. B. and Beck, T. (1993) "Recombinant human erythropoietin and the anemia of multiple myeloma". Stem Cell 11, 88-94.
  • Ludwig, H., Fritz. E., Leitgeb, C., Percherstorfer. M., Samonigg, H. and Schuster, J. (1994) "Prediction of response to erythropoictin treatment in chronic anemia of cancer". Blood 84, 1056-1063.
  • Varel, B., Casadevall. N., Lacombe, C. and Nayeaux. P. (1990) "Erythropoietin physiology and clinical experience". Seminars in Hematology 27, 25-31.
  • Erslev, A. (1991) "Erythropoietin", New England Journal of Medicine 324, 1339-1344.
  • Barlogie, B., Smallwood. L., Smith, T. and Alexanian, R. (1989) "High serum levels of lactic dehydrogenase identify a high grade lymphoma-like myeloma". Annals of Internal Medicine 110, 521-525.
  • Groux, H., Torpier, G., Monte, D., Mouton, B., Capron, A, and Ameisen. J.C. (1992) "Activation-induced death by apoptosis in CD4 + T cells from human immunodeficiency, virus-infected asymptomatic individuals". Journal of Experimental Medicine 175, 331-340.
  • Mountz, J.D., Wu. J., Cheng, J. and Zhou, T. (1994) "Autoimmune disease. A problem of defective apoptosis". Arthritis and Rheumatism 37, 1415 -1420.
  • Carson, D.A. and Ribeiro, J.M. (1993) "Apoptosis and diseases", The Lancet 341, 1251-1257.
  • Ameisen. J.C. (1994) "Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer", AIDS 8. 1197-1213.
  • Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Scherei French. L.E., Schneider. P., Bornard, T., Fontana. A., Cerottini, J. and Tschopp, J. (1996) "Melanoma cell expression of Fas (Apo-I/CD95) ligand: implication for tumor immune escape". Science 274, 1363-1366.
  • Saas. P, Walker, PR. Hahne, M. Quiquerez, A.L., Schnur Perrio. G., French. 1.,. Van Meir. E.G., de Tribolet, N. and Dietrich. P.Y. (1997) "Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?", Journal of Clinical investigation 99, 1173-1178.
  • O'Connel. J., O'Sullivan, J.K. and Shanahan, F. (1996) 'The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand", Journal of Experimental Medicine 184, 1075-1082.
  • Tanaka. M., Suda, T., Haze. K., Nakamura, N., Sato. K., Ki Motoyoshi, K., Miruki, M., Tagawa, S., Ohga, S., Hatake Drummond. A.H. and Nagata, S. (1996) "Fas ligand in human serum". Nature Medicine 2, 317-322.
  • Itoh. N., Yonehara, S., lshii. A., Yonehara. M., Mizushima. S., Sameshima. M., Hase. A., Seto, Y. and Nagata. S. (1991) "The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis". Cell 66, 233-243.
  • Shima, Y., Nishimoto, N., Ogata, A., Fujii. Y, Yoshizaki, K. and Kishimoto. T. (1995) "Myeloma cells express Fas antigen/APO-1 ICD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis". Blood 85, 757-764.
  • Westendorf. I.J., Lammert. J.M. and Jelinek, D.K (1995) "Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines", Blood 85, 3566-3576.
  • Villunger. A., Egle, A., Marschitz. I., Kos, M., Bock. G., Ludwig. H., Geley. S., Kofler. R. and Greil. R. (1997) "Constitutive expression of Fas (Apo-l/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance". Blood 90, 12-20.
  • Cheng. J., Zhou, T., Liu, C. Shapiro, J.P., Brauer. M.J., Keifer, M.C., Barr. P.J. and Mountz, J.D. (1994) "Protection from Fasmediated apoptosis by a soluble form of the Fas molecule". Science 263, 1759-1762.
  • Papoff, G., Cascino. I., Eramo, A., Starace, G., Lynch. D.H. and Ruberti. G. (1996) "An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitm". Journal of Immunology 156, 4622-4630.
  • Frassanito. M.A., Silvestris. F., Silvestris, N., Cafforio. P., Camarda. G., Iodice. G. and Dammacco. F. (1998) "Fas/Fas-ligand (Fas-1.)deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells". Clinical and Experimental Immunology 114, 179-188.
  • Wiley. S.R., Schooley, K., Smolak. P.J., Din. WS., Huang. C.P., Nicholl, J.K., Smith. T.D., Rauch. C. and Smith, C.A. (1995) "Identification and characterization of a new member of the TNF family that induces apoprosis", Immunity 3, 673-682.
  • Ashkenazi, A. and Dixit, V.M. (1999) "Apoptosis control by death and decoy receptors". Current Opinion in Cell Biology 11. 255-260.
  • Park. J.R. (1996) "Cytokine regulation of apoptosis in hematopoietic precursor cells", Current Opinion in Hematology 3, 191-196.
  • De Maria, R.,Testa, U., Lucchetti. L., Zeuner, A., Stassi, G., Pelosi, E., Riccioni. R., Felli. N., Samoggia. P. and Peschle. C. (1999) "Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis", Blood 93, 796-803.
  • Zamai. L., Secchiero, P., Pierpaoli, S., Bassini. A., Papa, S., Alnemri. E., Guidotti. L., Vitale. M. and Zauli. G. (2000) "TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis", Blood 95, 3716-3724.
  • Loken. M.R., Shah. V.O., Dattilio. K.L. and Civin. C.I. (1987) "Row cytometry analysis of human bone marrow. I: normal erythroid development". Blood 69, 255-263.
  • Labbaye. C., Valtieri. M., Barberi. T., Meccia, E., Masella. B., Pelosi. E., Condorelli. G.L., Testa, U. and Peschle. C. (1995) "Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis", Journal of Clinical Investigation 95, 2346-2358.
  • Orkin, S.H. (1992) "GATA-binding transcription factors in hematopoictic cells", Blood 80, 575-581.
  • Orkin. S.H. and Weiss, M.J. (1999) "Cutting red-cell production". Nature 401, 433-436.
  • De Maria, R., Zeuner, A., Eramo. A., Domenichelli. C., Bond. D., Grignani, F. and Srinivasula, S.M. (1999) "Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1". Nature 401, 489-493.
  • Pisa. P., Stenke. L., Bernell, P., Hansson. M. and Hast, R. (1990) "Tumor necrosis factor-a and interferon-? in serum of multiple myeloma patients", Anticancer Research 10, 817-820.
  • Bataille. R. and Harousseau. J.L. (1997) "Multiple myeloma". New England Journal of Medicine 336, 1657-1664.
  • Silvestris, R, Cafforio, P., Tucci. M. and Dammacco. F. (2002) "Negative regulation of erythroblast maturation by Fas-1. ' /TRAlL. highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma". Blond. 99, 1305-1313.
  • Dai. C. Price, J.O., Brunner, T. and Krantzu. S.B. (1998) "Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon-y to produce erythroid cell apoptosis", Blood 91, 1235-1241.
  • Killick. S.B., Cox. C.V., Marsh. J.C.W., Gordon-Smith. E.C. and Gibson. F.M. (2000) "Mechanisms of bone marrow progenitor cell apoptosis in aplastic anemia and the effect of anti-thymocyte globuli: examination of the role of the Fas-Fas-L interaction", British Journal of Haematology 111, 1164-1169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.